483 Amphastar Pharmaceuticals Feb 2019

483 Amphastar Pharmaceuticals Feb 2019

Philip Istafanos FDA, Ashar Parikh FDA$119.00 - Available Now

FDA investigators audited the Amphastar Pharmaceuticals - Rancho Cucamonga, CA, United States facility and issued inspectional observations (via FDA 483) on 12 Feb 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 12 Feb 2019
  • Location: Rancho Cucamonga, United States
  • FEI: 3002936358
Add To Cart